Medical device firm backed by Wisconsin investors gains FDA approval


The FDA gave HistoSonics market authorization for its Edison device, which destroys liver tumors with sound waves.

Previous SnapNurse triples tech investment, bets on AI in expansion
Next Procter & Gamble agrees to consolidation of industry-wide lawsuits against DayQuil, other decongestants